Dissecting OCT4 defines the role of nucleosome binding in pluripotency.


Journal

Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575

Informations de publication

Date de publication:
08 2021
Historique:
received: 01 08 2019
accepted: 01 07 2021
pubmed: 7 8 2021
medline: 21 9 2021
entrez: 6 8 2021
Statut: ppublish

Résumé

Pioneer transcription factors such as OCT4 can target silent genes embedded in nucleosome-dense regions. How nucleosome interaction enables transcription factors to target chromatin and determine cell identity remains elusive. Here, we systematically dissect OCT4 to show that nucleosome binding is encoded within the DNA-binding domain and yet can be uncoupled from free-DNA binding. Furthermore, accelerating the binding kinetics of OCT4 to DNA enhances nucleosome binding. In cells, uncoupling nucleosome binding diminishes the ability of OCT4 to individually access closed chromatin, while more dynamic nucleosome binding results in expansive genome scanning within closed chromatin. However, both uncoupling and enhancing nucleosome binding are detrimental to inducing pluripotency from differentiated cells. Remarkably, stable interactions between OCT4 and nucleosomes are continuously required for maintaining the accessibility of pluripotency enhancers in stem cells. Our findings reveal how the affinity and residence time of OCT4-nucleosome complexes modulate chromatin accessibility during cell fate changes and maintenance.

Identifiants

pubmed: 34354236
doi: 10.1038/s41556-021-00727-5
pii: 10.1038/s41556-021-00727-5
pmc: PMC7611526
mid: EMS129589
doi:

Substances chimiques

Chromatin 0
Nucleosomes 0
Octamer Transcription Factor-3 0
POU5F1 protein, human 0
SOX2 protein, human 0
SOXB1 Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-845

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M010996/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R008795/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M0180404/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N024028/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C65925/A26986
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Iwafuchi-Doi, M. & Zaret, K. S. Pioneer transcription factors in cell reprogramming. Genes Dev. 28, 2679–2692 (2014).
pubmed: 25512556 pmcid: 4265672 doi: 10.1101/gad.253443.114
King, H. W. & Klose, R. J. The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells. eLife 6, e22631 (2017).
pubmed: 28287392 pmcid: 5400504 doi: 10.7554/eLife.22631
Gaspar-Maia, A., Alajem, A., E, Meshorer. & M, Ramalho-Santos. Open chromatin in pluripotency and reprogramming. Nat. Rev. Mol. Cell Biol. 12, 36–47 (2011).
pubmed: 21179060 pmcid: 3891572 doi: 10.1038/nrm3036
Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106–1117 (2008).
pubmed: 18555785 doi: 10.1016/j.cell.2008.04.043
Soufi, A., Donahue, G. & Zaret, K. S. Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome. Cell 151, 994–1004 (2012).
pubmed: 23159369 pmcid: 3508134 doi: 10.1016/j.cell.2012.09.045
Knaupp, A. S. et al. Transient and permanent reconfiguration of chromatin and transcription factor occupancy drive reprogramming. Cell Stem Cell 21, 834–845.e6 (2017).
pubmed: 29220667 doi: 10.1016/j.stem.2017.11.007
Li, D. et al. Chromatin accessibility dynamics during iPSC reprogramming. Cell Stem Cell 21, 819–833.e6 (2017).
pubmed: 29220666 doi: 10.1016/j.stem.2017.10.012
Zviran, A. et al. Deterministic somatic cell reprogramming involves continuous transcriptional changes governed by Myc and epigenetic-driven modules. Cell Stem Cell 24, 328–341.e9 (2019).
pubmed: 30554962 doi: 10.1016/j.stem.2018.11.014
Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
pubmed: 16904174 doi: 10.1016/j.cell.2006.07.024
Chronis, C. et al. Cooperative binding of transcription factors orchestrates reprogramming. Cell 168, 442–459.e20 (2017).
pubmed: 28111071 pmcid: 5302508 doi: 10.1016/j.cell.2016.12.016
Chen, J. et al. Hierarchical Oct4 binding in concert with primed epigenetic rearrangements during somatic cell reprogramming. Cell Rep. 14, 1540–1554 (2016).
pubmed: 26832419 doi: 10.1016/j.celrep.2016.01.013
Soufi, A. et al. Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming. Cell 161, 555–568 (2015).
pubmed: 25892221 pmcid: 4409934 doi: 10.1016/j.cell.2015.03.017
Teif, V. B. et al. Genome-wide nucleosome positioning during embryonic stem cell development. Nat. Struct. Mol. Biol. 19, 1185–1192 (2012).
pubmed: 23085715 doi: 10.1038/nsmb.2419
Cirillo, L. A. et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279–289 (2002).
pubmed: 11864602 doi: 10.1016/S1097-2765(02)00459-8
Cirillo, L. A. et al. Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J. 17, 244–254 (1998).
pubmed: 9427758 pmcid: 1170375 doi: 10.1093/emboj/17.1.244
Cirillo, L. A. & Zaret, K. S. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol. Cell 4, 961–969 (1999).
pubmed: 10635321 doi: 10.1016/S1097-2765(00)80225-7
Iwafuchi-Doi, M. et al. The pioneer transcription factor FoxA maintains an accessible nucleosome configuration at enhancers for tissue-specific gene activation. Mol. Cell 62, 79–91 (2016).
pubmed: 27058788 pmcid: 4826471 doi: 10.1016/j.molcel.2016.03.001
Zhu, F. et al. The interaction landscape between transcription factors and the nucleosome. Nature 562, 76–81 (2018).
pubmed: 30250250 pmcid: 6173309 doi: 10.1038/s41586-018-0549-5
Fernandez Garcia, M. et al. Structural features of transcription factors associating with nucleosome binding. Mol. Cell 75, 921–932.e6 (2019).
pubmed: 31303471 doi: 10.1016/j.molcel.2019.06.009
Iwafuchi, M. et al. Gene network transitions in embryos depend upon interactions between a pioneer transcription factor and core histones. Nat. Genet. 52, 418–427 (2020).
pubmed: 32203463 pmcid: 7901023 doi: 10.1038/s41588-020-0591-8
Michael, A. K. et al. Mechanisms of OCT4–SOX2 motif readout on nucleosomes. Science 368, 1460–1465 (2020).
pubmed: 32327602 doi: 10.1126/science.abb0074
Tapia, N. et al. Dissecting the role of distinct OCT4–SOX2 heterodimer configurations in pluripotency. Sci. Rep. 5, 13533 (2015).
pubmed: 26314899 pmcid: 4551974 doi: 10.1038/srep13533
Nichols, J. et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379–391 (1998).
pubmed: 9814708 doi: 10.1016/S0092-8674(00)81769-9
Ambrosetti, D. C., Basilico, C. & Dailey, L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein–protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol. Cell. Biol. 17, 6321–6329 (1997).
pubmed: 9343393 pmcid: 232483 doi: 10.1128/MCB.17.11.6321
Avilion, A. A. et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126–140 (2003).
pubmed: 12514105 pmcid: 195970 doi: 10.1101/gad.224503
Remenyi, A. et al. Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers. Genes Dev. 17, 2048–2059 (2003).
pubmed: 12923055 pmcid: 196258 doi: 10.1101/gad.269303
Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947–956 (2005).
pubmed: 16153702 pmcid: 3006442 doi: 10.1016/j.cell.2005.08.020
Zaret, K. S. & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227–2241 (2011).
pubmed: 22056668 pmcid: 3219227 doi: 10.1101/gad.176826.111
Kong, X. et al. Functional interplay between the RK motif and linker segment dictates Oct4–DNA recognition. Nucleic Acids Res. 43, 4381–4392 (2015).
pubmed: 25870414 pmcid: 4482079 doi: 10.1093/nar/gkv323
Echigoya, K. et al. Nucleosome binding by the pioneer transcription factor OCT4. Sci. Rep. 10, 11832 (2020).
pubmed: 32678275 pmcid: 7367260 doi: 10.1038/s41598-020-68850-1
Jerabek, S. et al. Changing POU dimerization preferences converts Oct6 into a pluripotency inducer. EMBO Rep. 18, 319–333 (2017).
pubmed: 28007765 doi: 10.15252/embr.201642958
Huertas, J., MacCarthy, C. M., Schöler, H. R. & Cojocaru, V. Nucleosomal DNA dynamics mediate Oct4 pioneer factor binding. Biophysical J. 118, 2280–2296 (2020).
doi: 10.1016/j.bpj.2019.12.038
Zhou, K., Gaullier, G. & Luger, K. Nucleosome structure and dynamics are coming of age. Nat. Struct. Mol. Biol. 26, 3–13 (2019).
pubmed: 30532059 doi: 10.1038/s41594-018-0166-x
von Hippel, P. Protein–DNA recognition: new perspectives and underlying themes. Science 263, 769–770 (1994).
doi: 10.1126/science.8303292
Benchetrit, H. et al. Direct induction of the three pre-implantation blastocyst cell types from fibroblasts. Cell Stem Cell 24, 983–994.e7 (2019).
pubmed: 31031139 pmcid: 6561721 doi: 10.1016/j.stem.2019.03.018
Niwa, H., Masui, S., Chambers, I., Smith, A. G. & Miyazaki, J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 22, 1526–1536 (2002).
pubmed: 11839818 pmcid: 134688 doi: 10.1128/MCB.22.5.1526-1536.2002
Niwa, H., Miyazaki, J. & Smith, A. G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24, 372–376 (2000).
pubmed: 10742100 doi: 10.1038/74199
Smith, A. G. et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 336, 688–690 (1988).
pubmed: 3143917 doi: 10.1038/336688a0
Blomquist, P., Li, Q. & Wrange, Ö. The affinity of nuclear factor 1 for Its DNA site is drastically reduced by nucleosome organization irrespective of its rotational or translational position. J. Biol. Chem. 271, 153–159 (1996).
pubmed: 8550551 doi: 10.1074/jbc.271.1.153
Taylor, I. C., Workman, J. L., Schuetz, T. J. & Kingston, R. E. Facilitated binding of GAL4 and heat shock factor to nucleosomal templates: differential function of DNA-binding domains. Genes Dev. 5, 1285–1298 (1991).
pubmed: 2065977 doi: 10.1101/gad.5.7.1285
Mueller, B. et al. Widespread changes in nucleosome accessibility without changes in nucleosome occupancy during a rapid transcriptional induction. Genes Dev. 31, 451–462 (2017).
pubmed: 28356342 pmcid: 5393060 doi: 10.1101/gad.293118.116
Mieczkowski, J. et al. MNase titration reveals differences between nucleosome occupancy and chromatin accessibility. Nat. Commun. 7, 11485 (2016).
pubmed: 27151365 pmcid: 4859066 doi: 10.1038/ncomms11485
Voong, L. N. et al. Insights into nucleosome organization in mouse embryonic stem cells through chemical mapping. Cell 167, 1555–1570.e15 (2016).
pubmed: 27889238 pmcid: 5135608 doi: 10.1016/j.cell.2016.10.049
Iurlaro, M. et al. Mammalian SWI/SNF continuously restores local accessibility to chromatin. Nat. Genet. 53, 279–287 (2021).
pubmed: 33558757 doi: 10.1038/s41588-020-00768-w
Schick, S. et al. Acute BAF perturbation causes immediate changes in chromatin accessibility. Nat. Genet. 53, 269–278 (2021).
pubmed: 33558760 doi: 10.1038/s41588-021-00777-3
Hockemeyer, D. et al. A drug-inducible system for direct reprogramming of human somatic cells to pluripotency. Cell Stem Cell 3, 346–353 (2008).
pubmed: 18786421 pmcid: 4097107 doi: 10.1016/j.stem.2008.08.014
Kim, J. et al. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep. 3, 2088–2099 (2013).
pubmed: 23791528 pmcid: 3726210 doi: 10.1016/j.celrep.2013.05.036
Dyer, P. N. et al. Reconstitution of nucleosome core particles from recombinant histones and DNA. Methods Enzymol. 375, 23–44 (2003).
doi: 10.1016/S0076-6879(03)75002-2
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
pubmed: 22930834 pmcid: 5554542 doi: 10.1038/nmeth.2089
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).
pubmed: 24097267 pmcid: 3959825 doi: 10.1038/nmeth.2688
Sharma, D. et al. PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X–nucleosome. Nat. Commun. 10, 5751 (2019).
pubmed: 31848352 pmcid: 6917767 doi: 10.1038/s41467-019-13641-0
Esch, D. et al. A unique Oct4 interface is crucial for reprogramming to pluripotency. Nat. Cell Biol. 15, 295–301 (2013).
pubmed: 23376973 doi: 10.1038/ncb2680

Auteurs

Gareth A Roberts (GA)

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute of Stem Cell Research, University of Edinburgh, Edinburgh, UK.

Burak Ozkan (B)

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute of Stem Cell Research, University of Edinburgh, Edinburgh, UK.

Ivana Gachulincová (I)

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute of Stem Cell Research, University of Edinburgh, Edinburgh, UK.

Michael R O'Dwyer (MR)

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute of Stem Cell Research, University of Edinburgh, Edinburgh, UK.

Elisa Hall-Ponsele (E)

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute of Stem Cell Research, University of Edinburgh, Edinburgh, UK.

Manoj Saxena (M)

Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, London, UK.

Philip J Robinson (PJ)

Institute of Structural and Molecular Biology, Department of Biological Sciences, Birkbeck, University of London, London, UK.

Abdenour Soufi (A)

Centre for Regenerative Medicine, Institute for Regeneration and Repair, Institute of Stem Cell Research, University of Edinburgh, Edinburgh, UK. Abdenour.Soufi@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH